Credit Suisse Ag Opgen Inc Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$1.8 - $3.55 $69,832 - $137,725
-38,796 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$1.7 - $2.47 $65,953 - $95,826
38,796 New
38,796 $79,000
Q3 2020

Nov 13, 2020
SELL
$1.98 - $3.37 $43,900 - $74,719
-22,172 Closed
0 $0
Q2 2020

Aug 12, 2020
BUY
$1.88 - $2.59 $41,683 - $57,425
22,172 New
22,172 $45,000

Others Institutions Holding OPGN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About OPGEN INC

OPGN Quotes by TradingView
  • Ticker OPGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,698,500
  • Market Cap $40.3M
  • Description
  • OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants o...
More about OPGN
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email